amobarbital has been researched along with Adipocere in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levine, BS | 1 |
| Blanke, RV | 1 |
| Valentour, JC | 1 |
| Pounder, DJ | 1 |
| Jones, GR | 1 |
2 other studies available for amobarbital and Adipocere
| Article | Year |
|---|---|
Postmortem stability of barbiturates in blood and tissues.
Topics: Amobarbital; Barbiturates; Chromatography, Gas; Chromatography, Liquid; Humans; Liver; Pentobarbital | 1984 |
Post-mortem drug redistribution--a toxicological nightmare.
Topics: Adult; Amobarbital; Barbiturates; Clomipramine; Doxepin; Female; Flurazepam; Humans; Imipramine; Mal | 1990 |